secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELEFLEX INC (TFX)
CIK:        0000096943
Form:       8-K
Filed at:   2026-08-06T11:08:03+00:00
Accession:  0000096943-26-000091
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teleflex Q2 revenue up 4.7% pro forma; cuts revenue guidance, raises adjusted EPS outlook
--------------------------------------------------------------------------------

- Q2 revenue $570.3M (+28.9% reported, +4.7% pro forma adj. constant currency); GAAP EPS $0.96, adj. EPS $1.76.
- Full-year 2026 pro forma adj. constant currency revenue growth guidance reduced to 3.5%-4.5%; GAAP EPS cut to $2.54-$2.84.
- Adjusted EPS guidance raised to $6.90-$7.20; includes ~19% adj. operating margin and $250M share repurchase in Q2.
- Completed OEM divestiture for $1.5B cash; paid off $700M Term Loan A-2; new $500M 5.875% senior notes due 2032.
- FDA approved EZPLAZ freeze-dried plasma; Freesolve BIOMAG-II enrollment completed ahead of schedule.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/96943/000009694326000091/0000096943-26-000091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/96943/000009694326000091/tfx-20260806.htm
  HTML page:      https://secwatch.observer/filing/0000096943-26-000091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer